Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelstar vs Lupron or Zoladex in Advanced Prostate Cancer
NCT02749825Phase 4Terminated
- Sponsor
- Pharmatech, Inc.
- Start
- Sep 2002
- Primary completion
- May 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triptorelin in prostate cancer (PCa), sponsored by Pharmatech, Inc.. Started Sep 2002; status: terminated.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02749825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749825.